Literature DB >> 16791415

Secreted expression and purification of dengue 2 virus full-length nonstructural glycoprotein NS1 in Pichia pastoris.

Jun-mei Zhou1, Yun-xia Tang, Dan-yun Fang, Jing-jiao Zhou, Yu Liang, Hui-yu Guo, Li-fang Jiang.   

Abstract

The dengue 2 virus (DEN-2) RNA (NGC strain) was used as a substrate to produce DNA clones of the full-length NS1 genes via reverse transcriptase synthesis of cDNA followed by polymerase chain reaction amplification of the NS1 region. Products were cloned into pPICZalphaB vector for sequencing and into Pichia pastoris for expression. A recombinant protein with a molecular size of approximately 80 KDa was secreted into the supernatant from the yeast cells when induced with methanol. The expressed protein was able to bind with mouse polyclonal antibody or NS1-specific monoclonal antibody of dengue 2 virus. Purified NS1-poly(His)-tagged fusion protein was obtained from the expressed product by passing through a metal-chelating affinity chromatographic (MCAC) column. The study also verified that our purified rNS1 protein retained its antigenicity. High-level production of the rNS1 protein up to 70 mg/l indicates that P. pastoris is an efficient expression system for dengue virus full-length NS1 glycoprotein.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16791415     DOI: 10.1007/s11262-005-0036-6

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.198


  17 in total

1.  Growth restriction of dengue virus type 2 by site-specific mutagenesis of virus-encoded glycoproteins.

Authors:  M J Pryor; R C Gualano; B Lin; A D Davidson; P J Wright
Journal:  J Gen Virol       Date:  1998-11       Impact factor: 3.891

2.  Partial nucleotide sequence of the Murray Valley encephalitis virus genome. Comparison of the encoded polypeptides with yellow fever virus structural and non-structural proteins.

Authors:  L Dalgarno; D W Trent; J H Strauss; C M Rice
Journal:  J Mol Biol       Date:  1986-02-05       Impact factor: 5.469

3.  Expression of dengue virus structural proteins and nonstructural protein NS1 by a recombinant vaccinia virus.

Authors:  B T Zhao; G Prince; R Horswood; K Eckels; P Summers; R Chanock; C J Lai
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

4.  Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution.

Authors:  C M Rice; E M Lenches; S R Eddy; S J Shin; R L Sheets; J H Strauss
Journal:  Science       Date:  1985-08-23       Impact factor: 47.728

5.  The production of recombinant dengue virus E protein using Escherichia coli and Pichia pastoris.

Authors:  R J Sugrue; T Cui; Q Xu; J Fu; Y C Chan
Journal:  J Virol Methods       Date:  1997-12       Impact factor: 2.014

6.  Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1.

Authors:  J J Schlesinger; M W Brandriss; E E Walsh
Journal:  J Gen Virol       Date:  1987-03       Impact factor: 3.891

7.  The XXth century dengue pandemic: need for surveillance and research.

Authors:  S B Halstead
Journal:  World Health Stat Q       Date:  1992

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Immunoreactivity and protective effects in mice of a recombinant dengue 2 Tonga virus NS1 protein produced in a baculovirus expression system.

Authors:  X Qu; W Chen; T Maguire; F Austin
Journal:  J Gen Virol       Date:  1993-01       Impact factor: 3.891

10.  Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48.

Authors:  J J Schlesinger; M W Brandriss; E E Walsh
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

View more
  7 in total

1.  Differentially expressed genes of human microvascular endothelial cells in response to anti-dengue virus NS1 antibodies by suppression subtractive hybridization.

Authors:  Yue Yin; Lan Jiang; Danyun Fang; Lifang Jiang; Junmei Zhou
Journal:  Viral Immunol       Date:  2013-05-22       Impact factor: 2.257

2.  Recent advances on the GAP promoter derived expression system of Pichia pastoris.

Authors:  Ai-Lian Zhang; Jin-Xian Luo; Tian-Yuan Zhang; Ying-Wen Pan; Yan-Hua Tan; Ce-Yi Fu; Fa-zhi Tu
Journal:  Mol Biol Rep       Date:  2008-09-10       Impact factor: 2.316

3.  Dengue Virus Subverts Host Innate Immunity by Targeting Adaptor Protein MAVS.

Authors:  Zhenjian He; Xun Zhu; Weitao Wen; Jie Yuan; Yiwen Hu; Jiahui Chen; Shu An; Xinhuai Dong; Cuiji Lin; Jianchen Yu; Jueheng Wu; Yi Yang; Junchao Cai; Jun Li; Mengfeng Li
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

4.  Activation of Toll-like receptor 3 impairs the dengue virus serotype 2 replication through induction of IFN-β in cultured hepatoma cells.

Authors:  Zhaoduan Liang; Siyu Wu; Yuye Li; Li He; Minhao Wu; Lifang Jiang; Lianqiang Feng; Ping Zhang; Xi Huang
Journal:  PLoS One       Date:  2011-08-04       Impact factor: 3.240

5.  Optimization of Dengue-3 recombinant NS1 protein expression in E. coli and in vitro refolding for diagnostic applications.

Authors:  T N Athmaram; Shweta Saraswat; Princi Misra; Saurabh Shrivastava; Anil K Singh; Shailendra K Verma; N Gopalan; Prativa K Behara; P V L Rao
Journal:  Virus Genes       Date:  2012-11-28       Impact factor: 2.198

6.  High-level expression of functionally active dengue-2 non-structural antigen 1 production in Escherichia coli.

Authors:  S Gowri Sankar; K J Dhanajeyan; R Paramasivan; V Thenmozhi; B K Tyagi; S John Vennison
Journal:  Biomed Res Int       Date:  2013-09-08       Impact factor: 3.411

7.  Super induction of dengue virus NS1 protein in E. coli.

Authors:  Dipankar Das; Sunundha Mongkolaungkoon; Mavanur R Suresh
Journal:  Protein Expr Purif       Date:  2009-02-14       Impact factor: 1.650

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.